0001104659-20-139119.txt : 20201223 0001104659-20-139119.hdr.sgml : 20201223 20201223161930 ACCESSION NUMBER: 0001104659-20-139119 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201221 FILED AS OF DATE: 20201223 DATE AS OF CHANGE: 20201223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cheng Andrew CENTRAL INDEX KEY: 0001778307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 201412498 MAIL ADDRESS: STREET 1: 170 HARBOR WAY, 3RD FLOOR STREET 2: C/O AKERO THERAPEUTICS, INC. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tm2039296d1_4.xml OWNERSHIP DOCUMENT X0306 4 2020-12-21 0 0001744659 Akero Therapeutics, Inc. AKRO 0001778307 Cheng Andrew C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President & CEO Common Stock 2020-12-11 5 G 0 E 50 0 D 327509 D Common Stock 2020-12-15 5 G 0 E 2500 0 D 325009 D Common Stock 2020-12-21 4 M 0 10500 0.62 A 335509 D Employee Stock Option (Right to Buy) 0.62 2020-12-21 4 M 0 10500 0 D 2028-09-07 Common Stock 10500 286192 D The shares reported in this transaction represent a bona fide gift. The shares reported in this transaction represent a bona fide charitable gift to a donor advised fund. The Reporting Person does not have any pecuniary interest in the fund's assets. 25% of this option vested and became exercisable on September 1, 2019, with the remainder vesting in 36 equal monthly installments thereafter. /s/ Jonathan Young, Attorney-in-Fact 2020-12-23